Learn more

SIRNA THERAPEUTICS INC

Overview
  • Total Patents
    600
  • GoodIP Patent Rank
    13,594
  • Filing trend
    ⇩ 40.0%
About

SIRNA THERAPEUTICS INC has a total of 600 patent applications. It decreased the IP activity by 40.0%. Its first patent ever was published in 1994. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are SECARNA PHARMACEUTICALS GMBH & CO KG, ALNYLAM PHARMACEUTICALS and GERON CORP.

Patent filings per year

Chart showing SIRNA THERAPEUTICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Mcswiggen James 326
#2 Beigelman Leonid 237
#3 Vargeese Chandra 97
#4 Usman Nassim 67
#5 Haeberli Peter 66
#6 Pavco Pamela 64
#7 Stanton Matthew G 60
#8 Jadhav Vasant 55
#9 Zinnen Shawn 51
#10 Wang Weimin 51

Latest patents

Publication Filing date Title
US2018346913A1 Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
US2016053269A1 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
AU2015210336A1 RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)
US2015376613A1 Segmented micro RNA mimetics
US2016152973A1 Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
WO2015084850A1 Membrane translocation assay for sirna
WO2015070158A1 Systemic delivery of myostatin short interfering nucleic acids (sina) conjugated to a lipophilic moiety
US2015148530A1 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
WO2014130607A1 SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES CONTAINING A 2' INTERNUCLEOSIDE LINKAGE
WO2014126828A1 Novel ph-switchable peptides for membrane insertion and pore formation
AU2013361605A1 Post-synthetic orthogonal amidation plus metal catalyzed azide-alkyne cycloaddition click chemistry on siRNA
AU2013256341A1 Novel tetraGalNAc and peptide containing conjugates and methods for delivery of oligonucleotides
TW201808342A Novel tetraGALNAC containing conjugates and methods for delivery of oligonucleotides
EP3358013A1 Short interfering nucleic acid (sina) compositions
AU2013249548A1 Novel diester and triester based low molecular weight, biodegradable cationic lipids for oligonucleotide delivery
US2015057373A1 Diether based biodegradable cationic lipids for siRNA delivery
EP2640400A1 Poly(amide) polymers for the delivery of oligonucleotides
EP3766975A1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
EP2629802A2 Low molecular weight cationic lipids for oligonucleotide delivery
EP2609198A1 SINGLE-STRANDED RNAi AGENTS CONTAINING AN INTERNAL, NON-NUCLEIC ACID SPACER